Mitesco, Inc. Files Q3 2024 10-Q Report
Ticker: MITI · Form: 10-Q · Filed: Nov 25, 2024 · CIK: 802257
Sentiment: neutral
Topics: 10-Q, financials, healthcare
TL;DR
Mitesco filed its 10-Q for Q3 2024. Check financials.
AI Summary
Mitesco, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2024. The company, formerly known as True Nature Holding, Inc. and Trunity Holdings, Inc., is incorporated in Nevada and operates in the health services sector. Its principal business address is in Vero Beach, Florida.
Why It Matters
This filing provides investors with an update on Mitesco, Inc.'s financial performance and operational status for the third quarter of 2024.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new disclosures.
Key Players & Entities
- Mitesco, Inc. (company) — Registrant
- September 30, 2024 (date) — Quarter End Date
- True Nature Holding, Inc. (company) — Former Company Name
- Trunity Holdings, Inc. (company) — Former Company Name
- Nevada (location) — State of Incorporation
- 844-383-8689 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the quarter ended September 30, 2024.
What is the exact name of the company filing this report?
The exact name of the registrant is Mitesco, Inc.
In which state is Mitesco, Inc. incorporated?
Mitesco, Inc. is incorporated in Nevada.
What was Mitesco, Inc. formerly known as?
Mitesco, Inc. was formerly known as True Nature Holding, Inc. and Trunity Holdings, Inc.
What is the business address of Mitesco, Inc.?
The business address is 505 Beachland Blvd., Suite 1377, Vero Beach, FL 32963.
Filing Stats: 4,650 words · 19 min read · ~16 pages · Grade level 16.5 · Accepted 2024-11-25 17:04:22
Key Financial Figures
- $0.01 — Stockholders' deficit Preferred stock, $0.01 par value, 100,000,000 shares authorize
Filing Documents
- mitesco20240930_10q.htm (10-Q) — 2161KB
- ex_749090.htm (EX-31.1) — 13KB
- ex_749091.htm (EX-32.1) — 5KB
- 0001185185-24-001173.txt ( ) — 9715KB
- miti-20240930.xsd (EX-101.SCH) — 63KB
- miti-20240930_cal.xml (EX-101.CAL) — 50KB
- miti-20240930_def.xml (EX-101.DEF) — 330KB
- miti-20240930_lab.xml (EX-101.LAB) — 516KB
- miti-20240930_pre.xml (EX-101.PRE) — 342KB
- mitesco20240930_10q_htm.xml (XML) — 1528KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION Item 1.
Financial Statements (Unaudited)
Financial Statements (Unaudited) 4 Consolidated Balance Sheets as of September 30, 2024, and December 31, 2023 4 Consolidated Statements of Operations for the three and nine months ended September 30, 2024, and 2023 5 Consolidated Stockholder's Deficit for the three and nine months ended September 30, 2024, and 2023 6 Consolidated Statements of Cash Flows for the nine months ended September 30, 2024, and 2023 7
Notes to Consolidated Financial Statements
Notes to Consolidated Financial Statements 8 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations. 32 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk. 36 Item 4.
Controls and Procedures
Controls and Procedures. 36
– OTHER INFORMATION
PART II – OTHER INFORMATION Item 1. Legal Proceedings. 37 Item 1A. Risk Factors. 38 Item 2. Sale of Unregistered Securities. 39 Item 3. Defaults Upon Senior Secured Securities. 39 Item 4. Mine Safety Disclosures. 39 Item 5. Other Information. 39 Item 6. Exhibits. 39
Signatures
Signatures 41 Table of Contents
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS MITESCO, INC. CONSOLIDATED BALANCE SHEETS September 30, 2024 (Unaudited) December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 31,822 $ 2,838 Prepaids and other current assets 29,500 - Total current assets 61,322 2,838 Total assets $ 61,322 $ 2,838 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable and accrued liabilities $ 5,370,599 $ 7,838,112 Accrued interest 378,453 348,821 Accrued interest - related party 50,481 61,792 Derivative liabilities 152,945 152,945 Lease liability - operating lease, current 99,477 99,477 Notes payable, net 1,023,019 945,429 Notes payable - related parties, net 166,912 300,012 SBA loan payable 401,547 421,788 Other current liabilities 96,136 121,136 Preferred stock dividends payable 1,690,501 1,551,833 Preferred stock dividends payable - related parties 177,776 73,364 Legal settlements 2,452,768 2,219,886 Total current liabilities 12,060,614 14,134,595 Total liabilities 12,060,614 14,134,595 Stockholders' deficit Preferred stock, $0.01 par value, 100,000,000 shares authorized; 500,000 shares designated Series A; 3,000,000 shares designated Series C; 10,000,000 shares designated Series D; 10,000 shares designated as Series E; 140,000 shares designated as Series F, and 27,324 shares designated Series X. Preferred stock, Series A, $ 0.01 par value, 0 shares issued and outstanding as of September 30, 2024, and December 31, 2023 - - Preferred stock, Series C, $ 0.01 par value, 0 shares issued and outstanding as of September 30, 2024, and December 31, 2023 - - Preferred stock, Series D, $ 0.01 par value, 150,000 and 250,000 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively 1,500 2,500 Preferred stock, Series F, $ 0.01 par value, 14,665 and 20,057 shares issued and outstanding as of September 30, 2024, and D